Table 1 The clinical information of TARGET cohort and GSE21257 cohort.

From: A CIC-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma

 

TARGET_OS (N = 95)

GSE21257 (N = 53)

Overall (N = 148)

Sex

 Male

55 (57.9%)

34 (64.2%)

89 (60.1%)

 Female

40 (42.1%)

19 (35.8%)

59 (39.9%)

Age (years)

 Mean (SD)

15.4 (5.32)

18.7 (12.2)

16.6 (8.56)

 Median [Min, Max]

14.8 [3.56, 39.9]

16.7 [3.08, 79.0]

15.3 [3.08, 79.0]

Follow-up to main event (years)

 Mean (SD)

4.00 (3.00)

5.71 (4.94)

4.62 (3.88)

 Median [Min, Max]

3.33 [0.203, 16.0]

3.75 [0.333, 20.5]

3.48 [0.203, 20.5]

Status

 Alive

57 (60.0%)

30 (56.6%)

87 (58.8%)

 Dead

38 (40.0%)

23 (43.4%)

61 (41.2%)

Metastasis

 Yes

23 (24.2%)

34 (64.2%)

57 (38.5%)

 No

72 (75.8%)

19 (35.8%)

91 (61.5%)

Histologic response

 Stage 1/2

28 (29.5%)

29 (54.7%)

57 (38.5%)

 Stage 3/4

16 (16.8%)

18 (34.0%)

34 (23.0%)

 Unknown

51 (53.7%)

6 (11.3%)

57 (38.5%)

Back to article page